Search Our Website:

William Garvin, shareholder and Cannabis practice group leader; Tina Hu-Rodgers, counsel and Life Sciences industry group leader; and Natalie Oehlers, associate in the firm's FDA section coauthored "FDA Demands Congress Create New Regulatory Pathway for CBD" for the American Bar Association's Cannabis Law and Policy publication.